All Stories

  1. Crimean–Congo Hemorrhagic Fever Outbreak in Oman: Currently Emerging Situation and Mitigation Strategies
  2. Palivizumab for respiratory syncytial virus immunoprophylaxis in high-risk populations in Qatar: a call for action
  3. Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  4. Human Papilloma Virus Vaccination: Overcoming Barriers to Hesitancy in the GCC countries
  5. Oman Vision 2040: A Transformative Blueprint for a Leading Healthcare System with International Standards
  6. Cost-Effectiveness Analysis of Universal Rotavirus Vaccination Schedules in Syria
  7. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  8. Aspects to Enhance in the Quality of Life of Parents of Children with Central Nervous System Tumors
  9. Mpox in the Gulf Cooperation Council Countries
  10. Influence of Culture Among Users of Illegal Drugs: An Ethnographic Study
  11. Eating Behaviors during Pregnancy: A Cross-Sectional Study
  12. Post-Traumatic Psychological Experience of COVID-19 Survivors: A Descriptive Phenomenological Study
  13. Eating Behaviors during Pregnancy: A Cross-Sectional Study
  14. Support for Mandatory COVID-19 Vaccines for Children
  15. Burden of disease scenarios for 204 countries
  16. [Review Article] Drug Use Disorder and Coping Mechanisms Due to COVID-19 Lockdown Measures: A Cross-Sectional Survey
  17. Should we be concern about the Recent Avian Influenza Outbreaks?
  18. [Review Article] Drug Use Disorder and Coping Mechanisms Due to COVID-19 Pandemic Measures: A Cross-Sectional Survey
  19. Drug Use Disorder and Coping Mechanisms Due to COVID-19 Pandemic Measures: A Cross-Sectional Survey
  20. Elimination of Mother-to-Child Transmission of Hepatitis B Virus in Gulf Cooperation Council Countries: Current Status and Future Prospects
  21. Assessing Healthcare Providers' Preparedness for Managing COVID-19 Patients: A Mixed-Methods Study
  22. Reply to Hamzavi et al. Comment on “Islam et al. Helminth Parasites among Rodents in the Middle East Countries: A Systematic Review and Meta-Analysis. Animals 2020, 10, 2342”
  23. Non-pharmaceutical Interventions (NPIs) are strategies that individuals and communities
  24. Spontaneous remission of angioimmunoblastic T‑cell lymphoma
  25. Herpes Zoster Burden of Disease and Clinical Management in Turkey: A Comprehensive Literature Review
  26. Antimicrobial Stewardship Opportunities: An Example from Oman
  27. The Progress Towards National Malaria Elimination: The Experience of Oman
  28. Forecasting smoking deaths to 2050: a forecasting analysis for the global burden of disease study
  29. This review reports on the recent epidemiology of invasive meningococcal disease (IMD) the GCC
  30. Influenza Vaccine hesitancy in EMR
  31. An outbreak of human monkeypox (Hmpox) in multiple non-endemic countries
  32. Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries
  33. Oman's COVID-19 publication trends: A cross-sectional bibliometric study
  34. The Impact of Demographic, Clinical Characteristics and the Various COVID-19 Variant Types
  35. This study aimed to assess the acceptance of COVID-19 vaccine booster doses in the countries
  36. The Role of Psychological Factors and Vaccine Conspiracy Beliefs in Influenza Vaccine Hesitancy and Uptake among Jordanian Healthcare Workers during the COVID-19 Pandemic
  37. Assessing COVID-19 Vaccine’s Acceptability Amongst Health Care Workers in Oman
  38. Alarming Antibiotic Resistance in Pediatric Oncology Patients
  39. Knowledge, Attitude, and Acceptability of COVID-19 Vaccine in Oman
  40. Improving the process of employee recognition: An exploratory study
  41. Integrated Care for the Elderly in the Primary Health Care setting Oman: The Scope and Experience
  42. Weaning Practices Impact Factors and Outcomes an experiance from Oman
  43. A Systematic Review of Influenza Epidemiology and Surveillance in the Eastern Mediterranean and North African Region
  44. Hospitalized Patients with Moderate versus Severe COVID-19 Infection
  45. Our paper illustrated the importance of influenza vaccination among DM
  46. Living-Donor Liver Transplant in Oman: A Quantitative Cross-Sectional Study of Donors’ Experiences and Challenges
  47. Epidemiological Risk Factors for Acquiring Severe COVID-19
  48. This a work done by our countries
  49. Epidemiological Characteristics of Hepatitis B Positive Patients in Oman
  50. Epidemiological Characteristics of 69,382 COVID-19 Patients in Oman
  51. An Innovative Communication Approach to Mitigate Suffering Among COVID-19 Patients and Their Families: An Experience From Oman
  52. Role of primary healthcare in the response to COVID-19
  53. Levels of Physical Activity,
  54. Community Participation Approaches for Effective National COVID-19 Pandemic Preparedness and Response: An Experience From Oman
  55. Efforts for measles elimination in the Gulf Cooperation Council countries 2015–2019: A review
  56. Helminth Parasites among Rodents in the Middle East Countries
  57. Addressing Influenza Vaccination in MENA Region during the COVID-19 Pandemic: Decreasing the Effects of the Collision
  58. Influenza Vaccination Hesitancy among Healthcare Workers in Oman
  59. Preparing the Community for an upcoming Vaccine Against COVID-19
  60. Pneumococcal Meningitis Among Children in the Post-13-Valent Pneumococcal Conjugate Vaccine Era: Three Case Reports
  61. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017
  62. COVID 19 in Oman
  63. One Health operational framework for action for the Eastern Mediterranean Region
  64. The Omani experiences in presenting the first COVID 19 cases
  65. Oman, MERS-CoV
  66. This manuscript provided information on Health promotion strategy as part of Vision 2050 in Oman
  67. This paper gives over the situation of WPV globally and specifically in Oman.
  68. Assessment of Key Performance Indicators of the Primary Health Care in Oman
  69. Zoonotic Diseases in Oman: Successes, Challenges, and Future Directions
  70. assess the impact of non-pharmaceutical interventions on the COVID-19 epidemic in Oman
  71. Hepatitis B Elimination in GHC states
  72. MERS-Cov in Oman
  73. Dengue outbreak in Oman
  74. Influenza surveillance in MENA countries
  75. EMARIS report
  76. Successes and Challenges of HIV/AIDS Program in Oman: 1984–2015
  77. TB in Oman
  78. Assessment of hepatitis B immunization programme among school students in Qatar
  79. TB Elimination in GHC states
  80. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study.
  81. Assessment of safe injection practices in health facilities in Oman
  82. Pertussis control
  83. The manuscript provided the leprosy situation in Oman and the way forward
  84. Progress towards measles, rubella and congenital rubella syndrome elimination: Oman experience
  85. Early Clinical Manifestations of CRS
  86. Late Clinical Manifestations of Congenital Rubella Syndrome
  87. Epidemiology of Pandemic H1N1 in Oman and Public Health Response, 2009
  88. Dengue epidemiological trend in Oman: a 13-year national surveillance and strategic proposition of imported cases
  89. Cost effectiveness of a pentavalent rotavirus vaccine in Oman
  90. Molecular Epidemiology and Genotyping of Hepatitis B Virus of HBsAg-Positive Patients in Oman
  91. HPV epidemiological situation in EMR
  92. Progress toward Elimination of Hepatitis B Virus Transmission in Oman: Impact of Hepatitis B Vaccination
  93. Epidemiology of invasive pneumococcal infection among hospitalized children aged less than 5 years in Oman
  94. Absence of lymphatic filariasis infection among secondary-school children
  95. The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases in the Sultanate of Oman: Evidence-based approach and consensus decision-making
  96. Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study
  97. ocular manifestations of congenital rubella syndrome
  98. Poliomyelitis in Oman. I. The last outbreak?
  99. Poliomyelitis in Oman. II. Toward eradication